Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
8.29M
-
Shares change
-
-500K
-
Total reported value, excl. options
-
$60.2M
-
Value change
-
-$4.14M
-
Put/Call ratio
-
0.08
-
Number of buys
-
10
-
Number of sells
-
-18
-
Price
-
$7.29
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q2 2022
45 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q2 2022.
Profound Medical Corp. - Common Shares (PROF) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.29M shares
of 29.9M outstanding shares and own 27.73% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.71M shares), GAGNON SECURITIES LLC (1.33M shares), LETKO, BROSSEAU & ASSOCIATES INC (1.26M shares), FIL Ltd (1.09M shares), Timelo Investment Management Inc. (842K shares), ROYCE & ASSOCIATES LP (503K shares), Gagnon Advisors, LLC (441K shares), Zweig-DiMenna Associates LLC (256K shares), GILDER GAGNON HOWE & CO LLC (147K shares), and NATIONAL BANK OF CANADA /FI/ (118K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.